Maxhold Pharmaceutical Private Limited
About Maxhold Pharmaceutical Private Limited
Data last updated:
Maxhold Pharmaceutical Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 August 2023.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U21001KA2023PTC177207.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Bhavya Venkateshbabu and Peddanna Gari Ravi Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.08 Lakh, a growth of 115% compared to the previous year. For the same year it recorded a net loss of ₹18,063 (net margin -1.8%) and EBITDA of ₹19,276 (EBITDA margin 1.9%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressNo. 101 2nd Main Road, Mahalakshmi Layout Ananthapura Yelahanka, Bangalore, Karnataka, India – 560064
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Maxhold Pharmaceutical Private Limited
The main business activity of Maxhold Pharmaceutical is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Maxhold Pharmaceutical Private Limited FY 2025 filings available
Maxhold Pharmaceutical Private Limited reported revenue of ₹10.08 Lakh (up 115% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Maxhold Pharmaceutical Private Limited
Revenue rose 115% in the latest year. EBITDA rose 114% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Maxhold Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | ₹19,276 | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | -₹18,063 | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Maxhold Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 1.9% | •••• |
| Net Profit Margin | -1.8% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Maxhold Pharmaceutical are in the company report.
Financial statements from FY 2024
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Maxhold Pharmaceutical Private Limited
Maxhold Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Manufacture of basic pharmaceutical products and pharmaceutical preparations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ecostar Pharmaceuticals Private Limited | ₹10.53 Lakh (FY 2025) | •••• | •••• | 12.0% | •••• | Chalisgaon, Maharashtra, India |
| Vetify Private Limited | ₹10.27 Lakh (FY 2024) | •••• | •••• | 2370.0% | •••• | Varanasi, Uttar Pradesh, India |
| Dattatreya Ayurveda Herbs Private Limited | ₹10.26 Lakh (FY 2025) | •••• | •••• | •••• | Nadiad, Gujarat, India | |
| Swayogya Rehab Solutions Private Limited | ₹10.18 Lakh (FY 2024) | •••• | •••• | -55.0% | •••• | New Delhi, Delhi, India |
| Hoynoza Technologies Private Limited | ₹10.09 Lakh (FY 2025) | •••• | •••• | 7.0% | •••• | Bangalore, Karnataka, India |
| Maxhold Pharmaceutical Private Limited this company | ₹10.08 Lakh (FY 2025) | •••• | •••• | 115.0% | •••• | Bangalore, Karnataka, India |
| St. Clair Systems India Private Limited | ₹10.02 Lakh (FY 2025) | •••• | •••• | -77.0% | •••• | Kolhapur, Maharashtra, India |
| Dgi Chemicals Private Limited | ₹10 Lakh (FY 2023) | •••• | •••• | -45.0% | •••• | Mumbai, Maharashtra, India |
| Spanviz Healthcare Private Limited | ₹9.92 Lakh (FY 2025) | •••• | •••• | 26.0% | •••• | Pune, Maharashtra, India |
| Supriya Bio-Tech Private Limited | ₹9.65 Lakh (FY 2025) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Ambosys Pharmaceutical Private Limited | ₹9.61 Lakh (FY 2025) | •••• | •••• | -29.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Maxhold Pharmaceutical by revenue in the same principal business activity (Manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Maxhold Pharmaceutical Private Limited
Maxhold Pharmaceutical has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhavya Venkateshbabu | Director | 10 Aug 2023 | 3 Years 2 Months | Current |
| Peddanna Gari Ravi Kumar | Director | 10 Aug 2023 | 3 Years 2 Months | Current |
| Mohan Naresh | Director | 10 Aug 2023 | 3 Years 2 Months | Current |
| Krishnappa Smitha | Director | 10 Aug 2023 | 3 Years 2 Months | Current |
Charges & Borrowings of Maxhold Pharmaceutical Private Limited
Maxhold Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Maxhold Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Maxhold Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Maxhold Pharmaceutical Private Limited
Maxhold Pharmaceutical Private Limited has 4 board changes on record since 2023: 4 appointments. The latest: Bhavya Venkateshbabu was appointed as Director on 10 Aug 2023.
Credit Ratings, Litigation & Regulatory Alerts for Maxhold Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Maxhold Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Maxhold Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Maxhold Pharmaceutical Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Maxhold Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Maxhold Pharmaceutical Private Limited
Maxhold Pharmaceutical is an active private limited company based in Bangalore, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 August 2023 (3+ years old) and is registered under CIN U21001KA2023PTC177207.
Maxhold Pharmaceutical reported revenue of ₹10.08 Lakh for FY 2025 (up 115% YoY).
Maxhold Pharmaceutical has 4 current directors:
- Bhavya Venkateshbabu - Director
- Peddanna Gari Ravi Kumar - Director
- Mohan Naresh - Director
- Krishnappa Smitha - Director
Maxhold Pharmaceutical reported a net loss of ₹18,063 (net margin -1.8%) and EBITDA of ₹19,276 (EBITDA margin 1.9%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Maxhold Pharmaceutical is U21001KA2023PTC177207. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maxhold Pharmaceutical was incorporated on 10 August 2023, making it 3+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Maxhold Pharmaceutical by revenue are Ecostar Pharmaceuticals Private Limited, Vetify Private Limited, Dattatreya Ayurveda Herbs Private Limited, Swayogya Rehab Solutions Private Limited, Hoynoza Technologies Private Limited and 5 more, all in the same principal business activity (Manufacture of basic pharmaceutical products and pharmaceutical preparations).
Bhavya Venkateshbabu was appointed as Director on 10 Aug 2023. Krishnappa Smitha was appointed as Director on 10 Aug 2023. Mohan Naresh was appointed as Director on 10 Aug 2023. Maxhold Pharmaceutical has 4 board changes on record in total.
The registered office of Maxhold Pharmaceutical is at No. 101 2nd Main Road, Mahalakshmi Layout Ananthapura Yelahanka, Bangalore, Karnataka, India – 560064.
Maxhold Pharmaceutical has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh.
Maxhold Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.